Nanox Imaging is trading at $0.39, down 5.27%; no clear October 21 company-specific catalyst has been identified.

  • Its latest listed company releases are from October 16 and included preliminary Q3 revenue of $4.3–$4.4 million.
  • The update warned that cash may not support operations for at least one year, but does not establish the cause of the October 21 move.
  • Healthcare is reported up 2.12%, so sector strength does not explain the decline.